Procter & Gamble
PG
$142.24
-1.16%
Procter & Gamble is a global consumer defensive giant that manufactures and sells a vast portfolio of household and personal care products, including iconic brands like Tide, Pampers, Charmin, and Pantene. The company is a dominant market leader in its categories, distinguished by its unparalleled brand equity, massive scale, and extensive global distribution network. The current investor narrative centers on its resilience as a defensive staple during economic uncertainty, its ability to navigate persistent input cost pressures, and its ongoing strategy of premiumization and productivity savings to protect margins, as evidenced by recent news highlighting its status as a premier dividend growth stock with 69 consecutive years of increases.…
PG
Procter & Gamble
$142.24
Related headlines
Investment Opinion: Should I buy PG Today?
Rating & Thesis: Hold. PG is a high-quality, defensive dividend aristocrat trading at a full valuation amidst tepid growth, making it appropriate for income-focused portfolios but offering limited near-term capital appreciation upside. The analyst consensus leans bullish with recent upgrades, but the average target price implied by forward EPS suggests modest upside from current levels.
Supporting Evidence: The Hold rating is supported by four key data points: 1) A premium forward P/E of 20.70x versus likely sector averages in the low 20s, 2) Slowing revenue growth of 1.49% YoY, 3) Exceptional but potentially peak profitability with a 51.16% gross margin, and 4) A substantial but fully valued dividend yielding 2.52%. The stock's 7.95% decline over the past year and significant underperformance suggest the market is already pricing in these growth concerns, limiting further multiple compression.
Risks & Conditions: The two biggest risks are a growth stall leading to earnings misses and a sector-wide derating of premium valuations. This Hold would upgrade to a Buy if the forward P/E compresses below 18x (offering a better margin of safety) or if quarterly revenue growth re-accelerates sustainably above 3%. It would downgrade to a Sell if gross margins fall below 49% or if the stock breaks decisively below its 52-week low of $137.62. The valuation verdict is that PG is fairly valued to slightly overvalued relative to its immediate growth prospects, but the quality premium is justified for long-term, income-oriented investors.
Sign up to view all
PG 12-Month Price Forecast
PG is a fortress of stability in a volatile market, but its moat is currently priced for perfection. The neutral stance reflects the balance between its unparalleled financial strength (30.71% ROE, 2.52% yield) and its lack of a compelling growth narrative to drive multiple expansion. The base case of range-bound trading is most probable. The stance would upgrade to bullish if revenue growth re-accelerates above 3% without margin sacrifice, providing a catalyst for the stock to break its downtrend. It would turn bearish if the next quarterly report shows gross margin erosion below 50%, signaling the premiumization strategy is failing.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $184.91 and implied upside of +30.0% versus the current price.
Average Target
$184.91
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$114 - $185
Analyst target range
Analyst coverage for Procter & Gamble is robust, with the data indicating 7 analysts providing estimates, and recent institutional ratings showing a mix of Buy/Hold sentiments, including upgrades from JP Morgan to Overweight and Jefferies to Buy. The consensus leans bullish, with an average target price implied by estimated EPS and PE data, though a precise consensus target price is not explicitly provided in the data; the estimated EPS average for the forward period is $8.51. The target range, as inferred from estimated EPS, spans from a low of $8.43 to a high of $8.62, indicating a relatively tight spread and thus higher conviction among analysts about the company's near-term earnings power. The high target likely assumes successful execution of pricing strategies and cost savings, while the low target may factor in risks like volume erosion from pricing, commodity cost inflation, or competitive pressures. The pattern of recent ratings shows some positive momentum with upgrades, reinforcing the view of PG as a core defensive holding.
Bulls vs Bears: PG Investment Factors
The evidence presents a classic tension between quality and valuation. The bull case, anchored in PG's defensive cash flows, stellar profitability, and dividend aristocrat status, currently holds stronger fundamental evidence for long-term investors seeking stability. However, the bear case highlights significant near-term headwinds from stagnant growth and a full valuation that has led to substantial technical underperformance. The single most important tension in the investment debate is whether PG's premium valuation multiples (24.48x trailing PE) can be sustained in the face of mere 1-2% organic revenue growth, or if a period of multiple compression back toward sector averages is inevitable.
Bullish
- Exceptional Cash Flow & Dividend Safety: PG generates massive free cash flow of $14.85B TTM, yielding ~3.8% on market cap, which comfortably funds its dividend. This underpins its 69-year consecutive dividend growth record, a hallmark of financial resilience.
- Premium Profitability and Margins: The company maintains robust profitability with a gross margin of 51.16% and an operating margin of 24.2%. Its Return on Equity of 30.71% and Return on Assets of 10.93% are exceptionally strong for a mature consumer staple, indicating efficient use of capital.
- Defensive Low-Beta Profile: With a beta of 0.403, PG is approximately 60% less volatile than the broader market. This characteristic makes it a reliable capital preservation holding during market downturns, as evidenced by its relative outperformance in turbulent periods.
- Strong Balance Sheet: A manageable debt-to-equity ratio of 0.68 provides financial flexibility. This solid foundation, combined with high cash generation, reduces refinancing risk and supports strategic initiatives without excessive leverage.
Bearish
- Stagnant Revenue Growth: Recent quarterly revenue growth decelerated to just 1.49% YoY, down from stronger prior quarters. This tepid top-line expansion challenges the premium valuation and raises questions about market saturation and pricing power limits.
- Premium Valuation Relative to Sector: PG trades at a trailing PE of 24.48x and a forward PE of 20.70x, a premium to typical consumer staples averages. Its Price-to-Sales of 4.64x and EV/EBITDA of 17.43x also reflect a quality premium that leaves little room for error.
- Persistent Technical Downtrend: The stock is down 7.95% over the past year and underperformed the S&P 500 by 36.99%. Trading at ~55% of its 52-week range, it remains in a defined downtrend with key resistance at $170.99, requiring a significant catalyst to break out.
- High PEG Ratio Indicates Expensive Growth: A PEG ratio of 3.09 suggests the market is paying a high price for its expected earnings growth. This metric implies the stock's valuation may not be justified by its modest growth trajectory, increasing vulnerability to multiple compression.
PG Technical Analysis
The stock is in a defined downtrend and consolidation phase, having declined 7.95% over the past year and currently trading at approximately 55% of its 52-week range, with a current price of $147.26 relative to a 52-week high of $170.99 and low of $137.62. This mid-range positioning suggests the stock is neither at an extreme of momentum-driven overextension nor at a deep value trough, but rather in a period of indecision following a significant pullback from its highs. Recent momentum shows a modest 2.2% gain over the past month, which contrasts sharply with the negative 2.97% return over the past three months, indicating a potential stabilization or short-term bounce attempt within the context of a longer-term downtrend. This divergence could signal a temporary relief rally or the early stages of basing, though the stock's relative strength remains weak, underperforming the S&P 500 by 36.99% over the past year. Key technical levels are clearly defined by the 52-week low of $137.62 as major support and the 52-week high of $170.99 as formidable resistance; a decisive break below support would signal a continuation of the bearish trend, while a sustained move above resistance would require a significant fundamental catalyst. The stock's low beta of 0.403 indicates it is approximately 60% less volatile than the broader market, which is characteristic of a defensive consumer staple and implies smaller price swings, making it a lower-risk holding for capital preservation during market turbulence.
Beta
0.40
0.40x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$138-$171
Price range past year
Annual Return
-10.4%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | +8.2% |
| 3m | -11.8% | +9.0% |
| 6m | -3.7% | +10.5% |
| 1y | -10.4% | +26.5% |
| ytd | +0.3% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Revenue growth is modest but stable, with the most recent quarterly revenue of $22.21 billion representing a 1.49% year-over-year increase, though this marks a deceleration from the stronger growth seen in prior quarters like Q1 FY2026 (revenue of $22.39 billion). The Fabric Care and Home Care segment is the largest revenue driver at $7.69 billion, followed by Baby, Feminine and Family Care at $5.12 billion, indicating the core household essentials businesses continue to provide a steady foundation. The company is highly profitable, reporting net income of $4.33 billion and a robust gross margin of 51.16% for the last quarter, with operating margins holding steady around 24.2%. Profitability remains a key strength, with a trailing twelve-month free cash flow of $14.85 billion demonstrating exceptional cash generation, which comfortably funds dividends and share buybacks. The balance sheet is solid with a manageable debt-to-equity ratio of 0.68, and the company exhibits strong returns with a Return on Equity of 30.71% and a Return on Assets of 10.93%. The substantial free cash flow, which yields approximately 3.8% based on market cap, provides ample internal funding for operations and shareholder returns without reliance on excessive external financing, underpinning the company's financial health and dividend sustainability.
Quarterly Revenue
$22.2B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$14.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Given the consistently positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 24.48x and a forward PE of 20.70x, with the forward multiple being lower, indicating the market expects earnings growth. Compared to sector averages, Procter & Gamble's valuation is at a premium; for instance, its trailing PE of 24.48x is above typical consumer staples averages (often in the low 20s), while its Price-to-Sales ratio of 4.64x and EV/EBITDA of 17.43x also reflect a quality and stability premium that investors are willing to pay for its defensive characteristics and reliable cash flows. Historically, the current trailing PE of 24.48x sits above the lower end of its own historical range observed in the provided data (which has seen PEs from the high teens to over 30x), suggesting the stock is not at a bargain-basement level relative to its own history but is also not at peak optimism, positioning it in a fair value zone given its current growth profile.
PE
24.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~32x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: PG's primary financial risk is not solvency—its balance sheet is strong—but rather earnings stagnation and margin compression. Revenue growth has decelerated to 1.49% YoY, and while gross margins remain high at 51.16%, they are vulnerable to persistent input cost inflation, as highlighted by the European energy crisis. The company's valuation premium (P/E of 24.48x) is heavily dependent on maintaining these high margins and stable earnings; any significant erosion could trigger a sharp derating. Furthermore, with a payout ratio of 62%, dividend growth relies on continued earnings expansion, which is currently modest.
Market & Competitive Risks: The stock faces clear valuation compression risk, trading at a premium to sector averages on P/E, P/S, and EV/EBITDA metrics. In a rising interest rate environment or a market rotation away from defensive 'bond proxies,' these lofty multiples could contract. Competitively, the threat from value-oriented private labels intensifies during economic downturns, potentially forcing PG to choose between market share and pricing power. Its low beta of 0.403, while a defensive strength, also means it may lag significantly during broad market rallies, as evidenced by its 36.99% underperformance vs. the S&P 500 over the past year.
Worst-Case Scenario: A severe recession coupled with a spike in commodity costs triggers a perfect storm: consumers trade down to private labels en masse, volume declines outpace price increases, and operating margins compress by 300-400 basis points. Simultaneously, a hawkish Fed prompts a sector-wide derating of staple stocks. This could see PG's P/E compress to 18x (near the lower end of its historical range) on depressed earnings, driving the stock toward its 52-week low of $137.62. From the current price of $147.26, this represents a realistic downside of approximately -6.5% to that technical support level, with further downside possible if the 52-week low is breached.
FAQ
The key risks are: 1) Valuation Compression: The primary risk is its premium P/E multiple contracting if growth stalls or interest rates rise. 2) Stagnant Growth: Revenue growth of just 1.49% YoY may not justify its premium, leading to underperformance. 3) Margin Erosion: Input cost inflation (highlighted by European energy crises) and private label competition could pressure its robust 51.16% gross margin. 4) Sector Rotation: In a strong bull market, its low beta of 0.403 could cause it to lag significantly, as seen in its 36.99% underperformance vs. the S&P 500.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $150-$165, as it delivers consensus EPS of ~$8.51 but struggles with low growth. The Bull Case (25% probability) targets $170-$185, requiring a market downturn that favors defensives and sustained margin strength. The Bear Case (15% probability) risks a retest of the 52-week low near $137, triggered by margin pressure and multiple compression. The most likely outcome is range-bound trading, with total returns primarily from the dividend, as significant growth catalysts are not currently visible.
PG is fairly valued to slightly overvalued relative to its immediate growth prospects. Its trailing P/E of 24.48x and forward P/E of 20.70x command a premium to the broader consumer staples sector, which is typical for its quality and stability. However, a PEG ratio of 3.09 indicates the market is paying a high price for its expected growth. The valuation implies the market expects PG to maintain its industry-leading margins and slowly grow earnings, but leaves little room for error. Compared to its own 52-week high, the stock is down over 13%, suggesting some multiple compression has already occurred.
PG is a good buy for a specific type of investor: those seeking a low-volatility, dividend-growing stock for capital preservation and income. With a 2.52% yield backed by 69 years of increases and massive free cash flow, it offers safety. However, for investors seeking capital appreciation, it is less compelling due to its premium valuation (20.70x forward P/E) and tepid 1.49% revenue growth. The stock has underperformed the market significantly (-36.99% over one year), suggesting much of the bad news is priced in, but a clear catalyst for outperformance is lacking.
PG is unequivocally a long-term investment, with a suggested minimum holding period of 3-5 years to realize the benefits of dividend compounding and to ride out periods of valuation compression. Its low beta (0.403) and modest growth profile make it a poor candidate for short-term trading, as it lacks the volatility and catalyst-driven price swings traders seek. The investment thesis is based on durable competitive advantages, brand equity, and reliable cash generation over decades, not quarterly earnings beats. It is a foundational holding for building long-term wealth through reinvested dividends, not for tactical portfolio adjustments.